期刊文献+

胱抑素C与早期2型糖尿病患者颈动脉内膜中层厚度的相关性 被引量:26

Association of plasma cystatin C and intima-media thickness of carotid artery in patients with early type 2 diabetes mellitus
原文传递
导出
摘要 98例早期2型糖尿病患者,分为动脉粥样硬化(As)组和非As组,测定空腹血浆胱抑素C水平。结果显示,胱抑素C水平与颈动脉斑块数量显著相关(r=0.432,P〈0.01),胱抑素C是颈动脉内膜中层增厚的独立危险因素之一(OR=2.21,95%CI1.88~3.02)。 [ Summary ] Ninty-eight patients with newly diagnosed type 2 diabetes mellitus were divided into atherosclerosis(AS) group and non-AS group. Fasting plasma cystatin C level (CysC) was determined. The results showed that there existed a significant correlation between CysC level and the number of carotid arteries plaque ( r =0. 432 ,P〈0.01 ). CysC was an independent risk factor( OR = 2.21, 95% CI 1.88-3.02 ) of carotid artery intimamedia thickening in patients with type 2 diabetes.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2012年第1期29-31,共3页 Chinese Journal of Endocrinology and Metabolism
关键词 糖尿病 2型 胱抑素C 颈动脉内膜中层厚度 动脉粥样硬化 Diabetes mellitus, type 2 Cystatin C Carotid intima-media thickness Atherosclerosis
  • 相关文献

参考文献14

  • 1Arpegard J,Ostergren J,de Faire U,et al.Cystatin C a marker of peripheral atherosclerotic disease.Atherosclerosis,2008,199:397-401.
  • 2Kasami R,Kaneto H,Katakami N,et al.Relationship between carotid intima-media thickness and the presence and extent of coronary stenosis in type 2 diabetic patients with carotid atherosclerosis but without history of coronary artery disease.Diabetes Care,2011,34:468-470.
  • 3卢曙芳,沈建国,朱麒钱,官莉莉.2型糖尿病患者颈动脉内膜中层厚度与细胞间黏附分子1、C反应蛋白的相关性[J].中华内分泌代谢杂志,2006,22(4):358-359. 被引量:20
  • 4郭立新,潘琦,初明峰,郭发金,孙明晓,李慧,李铭,刘小萍.高同型半胱氨酸血症与糖尿病患者颈动脉内膜中层厚度关系及强化控制的影响[J].中华内分泌代谢杂志,2006,22(1):19-22. 被引量:51
  • 5王国萍,杜群,王国君,郎银枝,李华,郭小勇,武海霞,张银梅,郝丽芳.糖尿病肾病与颈动脉内膜中层厚度相关性研究[J].中华内分泌代谢杂志,2009,25(2):172-173. 被引量:5
  • 6Keller T,Messow CM,Lubos E,et al.Cystatin C and cardiovascular mortality in patients with coronary artery disease and normal or mildly reduced kidney function results from the AtheroGene study.J Eur Heart,2009,30:314-320.
  • 7Satoh-Asahara N,Suganami T,Majima T,et al.Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome.Clin J Am Soc Nephrol,2011,6:265-273.
  • 8Luc G,Bard JM,Lesueur C,et al.Plasma cystatin C and development of coronary heart disease:The PRIME Study.Atherosclerosis,2006,185:375-380.
  • 9Koenig W,Twardella D,Brenner H,et al.Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events more than simply a marker of glomerular filtration rate.Clin Chem,2005,51:321-327.
  • 10Tsai HT,Wang PH,Tee YT,et al.Imbalanced serum concentration between cathepsin B and cystatin C in patients with pelvic inflammatory disease.Fertil Steril,2009,91:549-555.

二级参考文献49

  • 1李振光,伍期专,唐朝枢,于占彩,王远臣,姚存姗,周慧杰,杨素国,于战涛.动脉粥样硬化患者颈动脉内膜中层厚度与血浆溶血磷脂酸含量的变化[J].中华医学杂志,2004,84(13):1071-1072. 被引量:20
  • 2卜瑞芳,邓振霞,沈泓,许岚,吴懿玲,蒋艳敏,华嘉临,张稷.血浆同型半胱氨酸水平与2型糖尿病合并脑梗死的关系[J].中华内分泌代谢杂志,2004,20(5):444-445. 被引量:39
  • 3朱麒钱,尤巧英,李成江,李红,沈建国,斯徐伟,官莉莉,俞钟明,楼大均,金华伟.C反应蛋白与2型糖尿病大血管病变危险因素的相关性研究[J].中华内分泌代谢杂志,2005,21(4):320-321. 被引量:104
  • 4刘英梅,傅岳武,孙立,韦育林,伍卫.γ粒子核素支架影响血管平滑肌细胞增殖与凋亡的实验研究[J].中国病理生理杂志,2007,23(5):884-887. 被引量:1
  • 5Fraley AE, Tsimikas S. Clinical applications of circulating oxidized low- density lipoprotein biomarkers in cardiovascular disease [ J ]. Curt Opin Lipidol, 2006,17 (5) :502 - 509.
  • 6Tsimikas S, Lau HK, Han KR, et al. Percutaneous coronary intervention results in acute increases in oxidized phospholipids and lipoprotein(a) : short - term and long - term immunologic responses to oxidized low- density lipoprotein[ J]. Circulation,2004,109(25 ) : 3164 - 3170.
  • 7Bokenkamp A, Herget - Rosenthal S, Bokenkamp R. Cystatin C, kidney function and cardiovascular disease [J]. Pediatr Nephrol,2006,21 (9) : 1223 -1230.
  • 8Lay IS, Hsieh CC, Chiu JH, et al. Salvianolic acid B enhances in vitro angiogenesis and improves skin flap survival in Sprague - Dawley rats [ J ]. J Surg Res, 2003,115 (2) : 279 - 285.
  • 9Bengtsson E, To F, Hakansson K, et al. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E - deficient mice[J ]. Arteriosclcr Thromb Vasc Biol,2005,25(10) : 2151 -2156.
  • 10Jormsjo S, Wuttge DM, Sirsjo A, et al. Differential expression of cysteine and aspartic proteases during progres- sion of atheroselerosis in apolipoprotein E -deficient mice [J].Am J Pathol, 2002, 161(3) : 939 -945.

共引文献103

同被引文献302

引证文献26

二级引证文献180

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部